首页> 美国卫生研究院文献>Springer Open Choice >A core-shell nanomaterial with endogenous therapeutic and diagnostic functions
【2h】

A core-shell nanomaterial with endogenous therapeutic and diagnostic functions

机译:具有内源性治疗和诊断功能的核壳纳米材料

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In the present communication, we report the fabrication of a unique core-shell inorganic nanomaterial with potential therapeutic and diagnostic functions. It contains an iron–cobalt (FeCo) core that demonstrates magnetic resonance imaging (MRI) contrast property and a thin nanoshell of gold that inhibits the function of a pro-angiogenic growth factor, VEGF165. Au(FeCo) core-shell nanomaterials are fabricated in the gas phase and characterized using transmission electron microscopy, energy dispersive spectrum, inductively coupled plasma analysis, and MRI. Inhibition of VEGF165 function by Au(FeCo) is demonstrated against VEGF165/VPF-induced signaling cascades and proliferation of human umbilical vein endothelial cells (HUVECs). The self-contrast property of Au(FeCo) is determined in vitro by MRI after incubating HUVECs with Au(FeCo), demonstrating intrinsic contrast property of this potentially therapeutic nanomaterial. In brief, we report here the successful fabrication of an inorganic core-shell nanomaterial with potential therapeutic and diagnostic functions. It inhibits the function of VEGF165 and functions as a MRI contrast agent.
机译:在本通讯中,我们报告了具有潜在治疗和诊断功能的独特核壳无机纳米材料的制造。它包含一个铁钴(FeCo)核,可以显示磁共振成像(MRI)的对比特性,以及一个薄的金纳米壳,可以抑制促血管生成生长因子VEGF165的功能。 Au(FeCo)核壳纳米材料是在气相中制备的,并使用透射电子显微镜,能量色散谱,电感耦合等离子体分析和MRI进行表征。已证明Au(FeCo)对VEGF165功能的抑制作用是针对VEGF165 / VPF诱导的信号级联反应和人脐静脉内皮细胞(HUVEC)的增殖。在将HUVEC与Au(FeCo)孵育后,通过MRI在体外确定Au(FeCo)的自对比度,证明了这种潜在治疗纳米材料的固有对比度。简而言之,我们在这里报告了具有潜在治疗和诊断功能的无机核-壳纳米材料的成功制备。它抑制VEGF165的功能,并作为MRI造影剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号